Discovery of a Fluoroindolo[2,3-a]carbazole Clinical Candidate with Broad Spectrum Antitumor Activity in Preclinical Tumor Models Superior to the Marketed Oncology Drug, CPT-11 - Mark G. Saulnier, Balu N. Balasubramanian, Byron H. Long, David B. Frennesson, Edward Ruediger, Kurt Zimmermann, Jeffrey T. Eummer, Denis R. St. Laurent, Karen M. Stoffan, B. Narasimhulu Naidu, Mikael Mahler, Francis Beaulieu, Carol Bachand, Frank Y. Lee, Craig R. Fairchild - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

American Chemical Society, Journal of Medicinal Chemistry, 7(48), p. 2258-2261, 2005

DOI: 10.1021/jm049090z

Links

Tools

Export citation

Search in Google Scholar

Discovery of a Fluoroindolo[2,3-a]carbazole Clinical Candidate with Broad Spectrum Antitumor Activity in Preclinical Tumor Models Superior to the Marketed Oncology Drug, CPT-11

Journal article published in 2005 by Mark G. Saulnier, Balu N. Balasubramanian, Byron H. Long, David B. Frennesson, Edward Ruediger, Kurt Zimmermann, Jeffrey T. Eummer, Denis R. St. Laurent, Karen M. Stoffan, B. Narasimhulu Naidu, Mikael Mahler, Francis Beaulieu, Carol Bachand, Frank Y. Lee, Craig R. Fairchild and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Must obtain written permission from Editor
Must not violate ACS ethical Guidelines

Upload

Orange circle

Postprint: archiving restricted

Must obtain written permission from Editor
Must not violate ACS ethical Guidelines

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO